Live feed
Filing
SC 13G
SC 13G0001214659-24-001942·LENZ Therapeutics, Inc.
Schedule 13G ownership disclosure
GRAPHITE BIO INC
Security class unavailable · CUSIP: 38870X104
Event date: 2024-01-24
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 5.4000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001214659-24-001942
- Form type
- SC 13G
- Filer
- LENZ Therapeutics, Inc.
- CIK
- CIK 1815776
- Filed
- Feb 05, 2024
- Reporting period
- Jan 24, 2024
- Description
- Schedule 13G beneficial ownership